Literature DB >> 16321743

Open four-compartment model in the measurement of liver perfusion.

Mika K Kapanen1, Juha T Halavaara, Anna-Maija Häkkinen.   

Abstract

RATIONALE AND
OBJECTIVES: The goal was to improve informativeness in the determination of liver perfusion with a clinically available iodinated computed tomography (CT) contrast agent by developing open multicompartmental modeling.
MATERIALS AND METHODS: Contrast-enhanced functional CT (fCT) examinations were conducted with temporal resolutions of 200-500 msec to 6 New Zealand White rabbits. First, we applied conventional open two-compartment model for the determination of arterial and portal blood flows (FA and FP), blood and interstitial volume fractions (fb and fi), and capillary permeability-surface area product (PS) of liver parenchyma. Then, we improved the modeling of vascular physiology by developing three- and open four-compartment models. For comparison, conventional single-compartment model was applied. We determined FA and FP also by using the peak-gradient method.
RESULTS: Conventional two-compartment model yielded identical fittings with single-compartment model and does not provide unique solutions for fb and fi. The presented open four-compartment model provided FA and FP values of 0.40 +/- 0.19 and 1.99 +/- 0.57 mL/min/mL (tissue), fb and fi values of 0.30 +/- 0.05 and 0.19 +/- 0.04 mL/mL (tissue), and PS values of 4.0 +/- 1.7 mL/min/mL (tissue). FA and FP are in a good agreement with those derived by using the peak-gradient method.
CONCLUSIONS: With the use of clinical extracellular iodinated CT contrast agent, the presented open four-compartment model provided physiological arterial and portal blood flow values and is also a potential tool in the assessment of blood and interstitial volume fractions and capillary permeability-surface area product. Moreover, the model requires neither measurements from hepatic vein or from other organs nor visual determination of arterial or portal phase.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16321743     DOI: 10.1016/j.acra.2005.07.001

Source DB:  PubMed          Journal:  Acad Radiol        ISSN: 1076-6332            Impact factor:   3.173


  6 in total

1.  Four-dimensional transcatheter intra-arterial perfusion MR imaging before and after uterine artery embolization in the rabbit VX2 tumor model.

Authors:  Johnathan C Chung; Dingxin Wang; Robert J Lewandowski; Richard Tang; Howard B Chrisman; Robert L Vogelzang; Gayle E Woloschak; Andrew C Larson; Reed A Omary; Robert K Ryu
Journal:  J Magn Reson Imaging       Date:  2010-05       Impact factor: 4.813

2.  Anatomically and physiologically informed computational model of hepatic contrast perfusion for virtual imaging trials.

Authors:  Thomas J Sauer; Ehsan Abadi; Paul Segars; Ehsan Samei
Journal:  Med Phys       Date:  2022-03-20       Impact factor: 4.506

3.  Four-dimensional transcatheter intraarterial perfusion (TRIP)-MRI for monitoring liver tumor embolization in VX2 rabbits.

Authors:  Dingxin Wang; Sumeet Virmani; Richard Tang; Barbara Szolc-Kowalska; Gayle Woloschak; Reed A Omary; Andrew C Larson
Journal:  Magn Reson Med       Date:  2008-10       Impact factor: 4.668

4.  Hepatic blood perfusion estimated by dynamic contrast-enhanced computed tomography in pigs: limitations of the slope method.

Authors:  Michael Winterdahl; Michael Sørensen; Susanne Keiding; Frank V Mortensen; Aage K O Alstrup; Søren B Hansen; Ole L Munk
Journal:  Invest Radiol       Date:  2012-10       Impact factor: 6.016

5.  Establishing models of portal vein occlusion and evaluating value of multi-slice CT in hepatic VX2 tumor in rabbits.

Authors:  Yue-Yong Qi; Li-Guang Zou; Ping Liang; Dong Zhang
Journal:  World J Gastroenterol       Date:  2007-06-28       Impact factor: 5.742

6.  Kinetics of intravenous radiographic contrast medium injections as used on CT: simulation with time delay differential equations in a basic human cardiovascular multicompartment model.

Authors:  D Violon
Journal:  Br J Radiol       Date:  2012-12       Impact factor: 3.039

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.